Profile data is unavailable for this security.
About the company
Zhejiang CONBA Pharmaceutical Co Ltd is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills, granules, powders, injections, oral solutions, syrups, eye drops, nasal drops, ear drops, ointments and others. Its products are applied in cardiovascular and cerebrovascular diseases, urinary system diseases, digestive diseases, respiratory diseases, endocrine system, nervous system, anti-infection and other treatment areas. The Company also provides value-added services. The Company distributes its products within domestic markets.
- Revenue in CNY (TTM)6.46bn
- Net income in CNY486.79m
- Incorporated1993
- Employees8.41k
- LocationZhejiang CONBA Pharmaceutical Co LtdNo. 568, Binkang Road, Binjiang DistrictHANGZHOU 310052ChinaCHN
- Phone+86 57 187774288
- Fax+86 57 187774722
- Websitehttp://www.conbapharm.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.58bn | 421.47m | 12.04bn | 1.55k | 29.07 | 4.60 | -- | 7.64 | 1.88 | 1.88 | 7.14 | 11.91 | 0.4286 | 1.19 | 3.67 | 1,020,281.00 | 11.58 | 5.86 | 16.99 | 7.59 | 67.12 | 55.41 | 27.01 | 17.20 | 0.912 | 24.02 | 0.3477 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Guobang Pharma Ltd | 5.71bn | 702.28m | 12.13bn | 4.23k | 17.22 | 1.55 | -- | 2.12 | 1.26 | 1.26 | 10.26 | 14.03 | 0.5599 | 3.29 | 7.84 | 1,350,536.00 | 6.87 | 10.36 | 8.88 | 14.24 | 23.87 | 27.49 | 12.27 | 15.01 | 1.70 | -- | 0.1992 | 18.24 | -6.49 | 10.28 | -33.49 | 23.77 | 35.60 | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.56bn | 675.80m | 12.23bn | 2.53k | 17.96 | 4.23 | -- | 3.43 | 1.20 | 1.20 | 6.34 | 5.10 | 0.7489 | 2.24 | 10.18 | 1,408,620.00 | 14.20 | 10.68 | 23.52 | 16.56 | 72.35 | 74.42 | 18.96 | 14.92 | 0.9579 | -- | 0.0073 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Tibet Rhodiola Pharmaceutical Holding Co | 2.94bn | 737.44m | 12.25bn | 601.00 | 14.74 | 3.38 | -- | 4.17 | 2.58 | 2.58 | 9.69 | 11.26 | 0.6264 | 1.54 | 6.79 | 4,894,779.00 | 15.80 | 12.44 | 20.83 | 15.71 | 93.36 | 90.51 | 25.22 | 20.43 | 3.44 | 7.74 | 0.1264 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.46bn | 486.79m | 12.26bn | 8.41k | 24.95 | 1.84 | -- | 1.90 | 0.1912 | 0.1912 | 2.54 | 2.59 | 0.618 | 2.39 | 4.56 | 768,224.60 | 4.98 | 6.77 | 6.93 | 10.50 | 51.47 | 63.24 | 8.06 | 11.10 | 1.24 | -- | 0.0781 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
| Holder | Shares | % Held |
|---|---|---|
| Kuwait Investment Authority (Investment Management)as of 30 Sep 2023 | 41.34m | 1.61% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 24.91m | 0.97% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 19.71m | 0.77% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 19.21m | 0.75% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 9.87m | 0.39% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2024 | 5.88m | 0.23% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 5.73m | 0.22% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 5.45m | 0.21% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 4.50m | 0.18% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 4.25m | 0.17% |
